Zydus Lifesciences informs about press release

09 Jun 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated June 9, 2023 titled ‘Zydus announces Phase IV EVIDENCES-XI trial to generate Real World Evidence of Saroglitazar Mg in Non-Alcoholic Fatty Liver Disease (NAFLD) patients with comorbidities.’

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

908.35 -1.65 (-0.18%)
17-Feb-2026 10:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.95
Dr. Reddys Lab 1266.10
Cipla 1346.00
Zydus Lifesciences 908.35
Lupin 2242.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×